[Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)].
This is a study of myelofibrosis concerning 2.786 bone marrow biopsies in malignant hemopathies, and cancers supposed to be metastatic. In a first group myelofibrosis is a permanent symptom and necessary for the diagnosis: agnogenic myeloid metaplasia, Waldenström's disease, hairy-cell leukemia, marrow extension of Hodgkin's disease and metastatic cancers. In a second group of hemopathies, myelofibrosis varies in frequency. Myeloid leukemia: 33% - Polycythemia: 40% - Thrombocythemia: 27% - Lymphoid leukemia: 17% - Acute leukemia: 20% - Kahler's disease: 30% - Aplastic anemia: 5% - Reticulin myelofibrosis is said possibly regressive. Collagen myelofibrosis is permanent.
D000208:Acute Disease; D001853:Bone Marrow / Q000473:pathology*; D006402:Hematologic Diseases / Q000473:pathology*; D006689:Hodgkin Disease / Q000473:pathology; D006801:Humans; D007938:Leukemia / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000473:pathology; D009196:Myeloproliferative Disorders / Q000473:pathology; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000473:pathology*; D055728:Primary Myelofibrosis / Q000209:etiology / Q000473:pathology*
La fibrose de la moelle osseuse dans les hémopathies malignes et les cancers. Etude histologique de 2 786 biopsies.